Rogério Lilenbaum

13.4k citations
105 papers · 8.4k · 1 hit paper · h-index 33

Impact in

  • Oncology top 0.2%
    • Lung Cancer Research Studies
    • Colorectal Cancer Treatments and Studies
    • Cancer Treatment and Pharmacology
    • Cancer Immunotherapy and Biomarkers
    • Lung Cancer Treatments and Mutations
    • Lung Cancer Diagnosis and Treatment

Papers in

    • Lung Cancer Treatments and Mutations 77
    • Lung Cancer Diagnosis and Treatment 42
    • Lung Cancer Research Studies 51
    • Colorectal Cancer Treatments and Studies 16
    • Cancer Treatment and Pharmacology 13

Rogério Lilenbaum

103 papers receiving 8.1k citations

Rogério Lilenbaum's Hit Papers

Paclitaxel–Carboplatin Alone or with Bevacizumab for Non–Small-Cell Lung Cancer 2006 · 4.5k citations
4.5k0+6+13Years since publication10002.0k3.0k4.0k

Peers

Rogério Lilenbaum
Comparison fields: 5 of 119
  • Oncology 5.6k
  • Pulmonary and Respiratory Medicine 5.5k
  • Cancer Research 1.2k
  • Hepatology 374
  • Molecular Biology 2.1k
Replace Philip Bonomi with:
Philip Bonomi United States
Alan B. Sandler United States
Maciej Krzakowski Poland
Ronald B. Natale United States
Glenwood Goss Canada
Christian Manegold Germany
Maya Gottfried Israel
Otilia Dalesio Netherlands
B. Findlay Canada
Denis Moro‐Sibilot France
Rogério Lilenbaum relative to Philip Bonomi United States Philip Bonomi's profile →
Citations per field
00.5×1.6×
Philip Bonomi · 1×
Citations per year

Countries citing papers authored by Rogério Lilenbaum

Since Specialization
Citations

This map shows the geographic impact of Rogério Lilenbaum's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Rogério Lilenbaum with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Rogério Lilenbaum more than expected).

Fields of papers citing papers by Rogério Lilenbaum

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Rogério Lilenbaum. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Rogério Lilenbaum. The network helps show where Rogério Lilenbaum may publish in the future.

Co-authors

The 25 scholars most cited alongside Rogério Lilenbaum, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Rogério Lilenbaum Line = papers co-authored together Rogério Lilenbaum links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 105 papers — load more, or switch the sort, to bring in the rest.

#Work
1
Paclitaxel–Carboplatin Alone or with Bevacizumab for Non–Small-Cell Lung Cancer
Hit paper breakdown →
20064492
2 2004352
3 2014291
4 2013234
5 2008164
6 2013161
7 2003159
8 2006150
9 2008149
10 2007140
11 1993111
12 2005106
13 199889
14 201886
15 200384
16 201080
17 199474
18 200161
19 200560
20 200653

About Rogério Lilenbaum

Rogério Lilenbaum is a scholar working on Pulmonary and Respiratory Medicine, Oncology, Molecular Biology, Epidemiology and Surgery, having authored 105 papers that have together received 8.4k indexed citations. Recurring topics across this work include Lung Cancer Treatments and Mutations (77 papers), Lung Cancer Research Studies (51 papers), Lung Cancer Diagnosis and Treatment (42 papers), Colorectal Cancer Treatments and Studies (16 papers), Cancer therapeutics and mechanisms (14 papers), Cancer Treatment and Pharmacology (13 papers), Neuroendocrine Tumor Research Advances (6 papers) and Hepatocellular Carcinoma Treatment and Prognosis (5 papers). The work is most often cited by research in Oncology (5.6k citations), Pulmonary and Respiratory Medicine (5.5k citations), Cancer Research (1.2k citations), Hepatology (374 citations) and Molecular Biology (2.1k citations). Rogério Lilenbaum has collaborated with scholars based in United States, United Kingdom and Ireland. Frequent co-authors include Afshin Dowlati, Michael C. Perry, Joan H. Schiller, Julie R. Brahmer, Alan Sandler, David H. Johnson, Robert J. Gray, Mark A. Socinski, Gregory A. Masters and Richard L. Schilsky. Their work appears in journals such as Journal of Clinical Oncology, Journal of Thoracic Oncology, Clinical Lung Cancer, Lung Cancer and Cancer.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact